Disseminated Breast Cancer: Palliateve Treatment With Doxorubicin-HPMA-Hulg

Number of the records: 1

1.

SYSNO ASEP	0154696
Document Type	C - Proceedings Paper (int. conf.)
R&D Document Type	Conference Paper
Title	Disseminated Breast Cancer: Palliateve Treatment With Doxorubicin-HPMA-Hulg
Author(s)	Říhová, Blanka (MBU-M)_RID Strohalm, Jiří (UMCH-V) Prausová, J. (CZ) Jelínková, Markéta (MBU-M) Rozprymová, L. (CZ) Šírová, Milada (MBU-M)_{RID, ORCID} Plocová, Daniela (UMCH-V) Etrych, Tomáš (UMCH-V)_{RID, ORCID} Mrkvan, Tomáš (MBU-M) Kovář, Marek (MBU-M)_{RID, ORCID}
Source Title	Winter Symposium a International Symposium on Recent Advances in Drug Delivery Systems /11./. - Utah, 2003
Pages	s. 56-57
Number of pages	2 s.
Action	Winter Symposium a International Symposium on Recent Advances in Drug Delivery Systems /11./
Event date	03.03.2003-06.03.2003
VEvent location	Utah
Country	US - United States
Event type	WRD
Language	eng - English
Country	US - United States
Keywords	hpma ; hulg
Subject RIV	EE - Microbiology, Virology
CEZ	AV0Z4050913 - UMCH-V
	AV0Z5020903 - MBU-M
Annotation	N-(2-hydroxypropyl) methacrylamidecopolymer (HPMA)-bound doxorubicin containing IVIg represents a new strategy for the treatment of cancer.
Workplace	Institute of Microbiology
Contact	Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
Year of Publishing	2004

Number of the records: 1